ISRCTN92669260CompletedNot Applicable
Randomised trial of two schedules of chemotherapy of the same dose/time intensity in untreated small cell lung cancer (SCLC) of poor prognosis
K Co-ordinating Committee for Cancer Research (UKCCCR)0 sites0 target enrollmentStarted: July 1, 2001Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Histologically or cytologically proven small cell carcinoma of the lung
- •2. Aged 75 or under
- •3. Extensive disease and poor prognosis, ie Eastern Cooperative Oncology Group (ECOG) performance status 2 or 3 and/or alkaline phosphatase >1.5 upper limit of normal range
- •4. Adequate renal function
- •5. No previous malignancy, except non melanomatous skin cancer in the preceding 3 years
- •6. No previous chemotherapy or radiotherapy, except for emergency radiotherapy for superior vena cava obstruction
- •7. No medical contraindications to treatment
Exclusion Criteria
- •Not provided at time of registration
Investigators
Similar Trials
Completed
Not Applicable
A Randomised Trial of Two Chemotherapy Regimens in the Treatment of Operable Osteosarcoma (Doxorubicin-Cisplatin versus Methotrexate-Vincristine-Doxorubicin plus Doxorubicin-Cisplatin plus Bleomycin-Cyclophosphamide-Dactinomycin)Bone cancerOsteosarcomaCancerISRCTN11824145Medical Research Council (MRC) (UK)400
Active, not recruiting
Not Applicable
A Randomized Phase II Study of two chemotherapy regimens, Pemetrexed-Carboplatin, and Gemcitabine-Vinorelbine, in Anthracycline and Taxane Pretreated Advanced Breast Cancer Patients - NDWomen with histologic or cytologic diagnosis of advanced breast cancer, who have received one prior chemotherapy containing anthracyclines as neo adjuvant or palliative 1st-line treatment and one prior chemotherapy containing taxanes as neo adjuvant or palliative 1st-line treatment.MedDRA version: 8.1Level: LLTClassification code 10055113Term: Breast cancer metastaticEUCTR2006-000441-19-ITELI LILLY160
Active, not recruiting
Not Applicable
A randomised Phase II study of two chemotherapy regimens, Pemetrexed-Carboplatin, and Gemcitabine-vinorelbine, in Anthracycline and Taxane pretreated Advanced Breast cancer patients.advanced breast cancerMedDRA version: 8.0Level: LLTClassification code 10006285EUCTR2006-000441-19-DEEli lilly and Company Limited144
Completed
Phase 2
Randomized phase II study comparing chemotherapy led by using the classification of primary tumor origin with empirical chemotherapy for patients with unknown primary cancer .JPRN-UMIN000001919Ministry of Health, Labour and Welfare scientific research Nakagawa squad120
Active, not recruiting
Not Applicable
Strain sUrveillance during Chemotherapy for improving Cardiovascular OUtcomesACTRN12614000341628Menzies Research Institute Tasmania331